Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Operations

v3.20.4
Unaudited Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]        
Revenues $ 47,210 $ 61,285 $ 174,193 $ 107,782
Operating expenses        
Cost of product sold 110,465 48,475 340,161 194,975
Selling, general and administrative 398,964 644,569 832,293 672,676
Amortization of intangibles 166,666 333,333
Total operating expenses 509,429 859,710 1,172,454 1,200,984
Loss from operations (462,219) (798,425) (998,261) (1,093,202)
Interest expense – bank debt 338 675
Interest expense - shareholder 125,575 15,738 209,530 42,336
(Gain)/loss on extinguishment of debt upon notes conversion (186,181)   2,216
Change in derivative liability (57,294) (165,563) (264,818) (355,625)
Interest expense - other 254,048 449,169 576,787 831,436
Other expense- non cash 39,173 19,877 39,173
Total other expense 136,486 338,517 544,267 557,320
Provision for income tax
Net loss $ (598,705) $ (1,136,942) $ (1,542,528) $ (1,650,522)
Basic and diluted net loss per common share $ (0.01) $ (0.02) $ (0.03) $ (0.03)
Weighted average shares of capital outstanding - basic and diluted 66,744,545 56,167,120 65,093,781 55,324,416